Skip to main content
Fig. 14 | BMC Cancer

Fig. 14

From: Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer

Fig. 14

Forest Plot of Progression-free Survival Treatment Comparison: TNBC Subgroup Analysis. Estimates derived only from indirect comparisons shown in black box. Included references: Study 301 (Kaufman 2015), CA163–046 (Rugo 2018), Sparano 2010. Abbreviations: CAP = capecitabine; CrI = credible interval; ERI = eribulin; IXA = ixabepilone; TNBC = triple negative breast cancer

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us